Divarasib Versus Adagrasib or Sotorasib in Pretreated KRAS G12C+Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Gadgeel, S. [1 ]
Rahman, A. [2 ]
Osaghae, U. [3 ]
Fernando, T. M. [3 ]
Lin, M. T. [3 ]
Koli, K. [3 ]
Meyenberg, C. [4 ]
Mathisen, M. [3 ]
Skoulidis, F. [5 ]
机构：
[1] Henry Ford Hlth, Henry Ford Canc Inst, Detroit, MI USA
[2] F Hoffmann La Roche Ltd, Welwyn Garden City, Herts, England
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] F Hoffmann La Roche Ltd, Basel, Switzerland
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.12D.07
引用
收藏
页码：S349 / S349
页数：1
相关论文
共 50 条
  • [31] KRYSTAL-12: Phase 3 study of adagrasib versus docetaxel in patients with previously treated advanced/metastatic non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation
    Mok, Tony S. K.
    Yao, Wenxiu
    Duruisseaux, Michael
    Doucet, Ludovic
    Azkarate Martinez, Aitor
    Gregorc, Vanesa
    Juan-Vidal, Oscar
    Lu, Shun
    De Bondt, Charlotte
    de Marinis, Filippo
    Linardou, Helena
    Kim, Young-Chul
    Jotte, Robert M.
    Felip, Enriqueta
    Lo Russo, Giuseppe
    Reck, Martin
    Michenzie, Mary F.
    Yang, Wenjing
    Meade, Julie N.
    Barlesi, Fabrice
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA8509 - LBA8509
  • [32] Real World Efficacy and Safety of Sotorasib in US Veterans with KRAS G12C Mutated Non-Small Cell Lung Cancer
    Zhou, K. I.
    Lin, C.
    Tseng, C. -L.
    Ramnath, N.
    Dowell, J. E.
    Kelley, M. J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S337 - S338
  • [33] Sotorasib versus docetaxel for previously treated non-small cell lung cancer with KRAS G12C mutation: CodeBreaK 200 phase III study
    Johnson, M. L.
    de langen, A. J.
    Waterhouse, D. M.
    Mazieres, J.
    Dingemans, A-M. C.
    Mountzios, G.
    Pless, M.
    Wolf, J.
    Schuler, M.
    Lena, H.
    Skoulidis, F.
    Okamoto, I.
    Kim, S-W.
    Linardou, H.
    Novello, S.
    Chen, Y.
    Solomon, B.
    Obiozor, C.
    Wang, Y.
    Paz-Ares, L.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1417 - S1418
  • [34] Liquid biopsy to track KRAS G12C mutation at progressive disease in patients with advanced non-small cell lung cancer (NSCLC)
    De Renzi, G.
    Nicolazzo, C.
    Pisegna, S.
    Belardinilli, F.
    Bottillo, I.
    Grammatico, P.
    Giannini, G.
    Gelibter, A. J.
    Gazzaniga, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S983 - S983
  • [35] Sotorasib as First-Line Treatment for Advanced KRAS G12C-Mutated Non-Small Cell Lung Carcinoma: A Case Report
    Iska, Sindu
    Alley, Evan W.
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 183 - 187
  • [36] Role of gefitinib (G) in heavily pretreated non-small cell lung cancer (NSCLC)
    Tamburini, E.
    Tassinari, D.
    Pasquini, E.
    Papi, M.
    Possenti, C.
    Drudi, F.
    Castellani, C.
    Santelmo, C.
    Carloni, F.
    Ravaioli, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer
    Alessandro Di Federico
    Ilaria Ricciotti
    Valentina Favorito
    Sandra Vietti Michelina
    Pietro Scaparone
    Giulio Metro
    Andrea De Giglio
    Federica Pecci
    Giuseppe Lamberti
    Chiara Ambrogio
    Biagio Ricciuti
    Current Oncology Reports, 2023, 25 : 1017 - 1029
  • [38] Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer
    Di Federico, Alessandro
    Ricciotti, Ilaria
    Favorito, Valentina
    Michelina, Sandra Vietti
    Scaparone, Pietro
    Metro, Giulio
    De Giglio, Andrea
    Pecci, Federica
    Lamberti, Giuseppe
    Ambrogio, Chiara
    Ricciuti, Biagio
    CURRENT ONCOLOGY REPORTS, 2023, 25 (09) : 1017 - 1029
  • [39] Sotorasib: a KRASG12C inhibitor for non-small cell lung cancer
    Ganguly, Arghya
    Yoo, Euna
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (06) : 536 - 537
  • [40] VP4-2023: Sotorasib 960 mg versus 240 mg in pretreated KRAS G12C advanced NSCLC
    Hochmair, M. J.
    Vermaelen, K.
    Mountzios, G.
    Carcereny, E.
    Dooms, C.
    Lee, S. -h.
    Morocz, E. M.
    Kato, T.
    Ciuleanu, T-e.
    Dy, G.
    Parente, M. B. M. C. S.
    O'Byrne, K. J.
    Chu, Q. s -c.
    De Castro Jr, G.
    Girard, N.
    Snyder, W.
    Tran, Q.
    Kormany, W.
    Houk, B.
    Curioni-Fontecedro, A.
    ANNALS OF ONCOLOGY, 2024, 35 (01) : 142 - 144
12345